Semba Charles Pauling 4
4 · DiaMedica Therapeutics Inc. · Filed Jan 3, 2023
Insider Transaction Report
Form 4
Semba Charles Pauling
Director
Transactions
- Award
Voting Common Shares, no par value per share
2023-01-03$1.53/sh+17,156$26,249→ 17,156 total
Footnotes (1)
- [F1]These shares are issuable upon vesting of a restricted stock unit award granted under the DiaMedica Therapeutics Inc. 2019 Omnibus Incentive Plan in lieu of cash retainer fees in the aggregate amount of $26,250. The restricted stock unit award will vest in four nearly equal installments on each of March 31, 2023, June 30, 2023, September 30, 2023 and December 31, 2023.